Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PRXL - Parexel International -- Ignore unavailable to you. Want to Upgrade?

To: Milk who wrote (50)	6/25/1999 2:17:00 PM
From: George Sepetjian	Read Replies (1) \| Respond to of 62

A couple of downgrades Parexel International Cut to 'Buy' at Dain Rauscher Princeton, New Jersey, June 25 (Bloomberg Data) -- Parexel International Corp. (PRXL US) was downgraded to ''buy'' from ''strong buy'' by analyst James Patricelli at Dain Rauscher Wessels. The 12-month target price is $20.00 per share. Parexel International Cut to 'Hold' at Tucker Cleary Princeton, New Jersey, June 25 (Bloomberg Data) -- Parexel International Corp. (PRXL US) was downgraded to ''hold'' from ''accumulate'' by analyst Charles C. Duncan Phd at Tucker Cleary Capital Markets.